Taro Pharmaceutical
TARO
#5055
Rank
$1.61 B
Marketcap
$42.97
Share price
0.00%
Change (1 day)
8.18%
Change (1 year)

Taro Pharmaceutical (TARO) - Total liabilities

Total liabilities on the balance sheet as of December 2023 : $0.38 Billion USD

According to Taro Pharmaceutical's latest financial reports the company's total liabilities are $0.38 Billion USD. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Taro Pharmaceutical - Total liabilities on balance sheet (from 2001 to 2023)

Total liabilities by year

Year Total liabilities Change
2023-03-31$0.40 B-12.96%
2022-03-31$0.46 B-34.65%
2021-03-31$0.71 B207.32%
2020-03-31$0.23 B3.25%
2019-03-31$0.22 B0.63%
2018-03-31$0.22 B3.18%
2017-03-31$0.21 B-13.93%
2016-03-31$0.25 B-21.69%
2015-03-31$0.32 B21.45%
2014-03-31$0.26 B22.31%
2013-03-31$0.21 B
2011-12-31$0.22 B30.74%
2010-12-31$0.17 B-38.64%
2009-12-31$0.28 B-9.29%
2008-12-31$0.30 B-6.43%
2007-12-31$0.33 B-11.95%
2006-12-31$0.37 B-10.77%
2005-12-31$0.42 B28.08%
2004-12-31$0.32 B22.67%
2003-12-31$0.26 B144.1%
2002-12-31$0.10 B23.61%
2001-12-31$88.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
$115.63 B 30,006.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$77.63 B 20,113.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$113.53 B 29,460.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$32.60 B 8,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
$61.28 B 15,855.91%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
$62.53 B 16,182.03%๐Ÿ‡จ๐Ÿ‡ญ Switzerland